Show simple item record

dc.contributor.authorBrogden, DRL
dc.contributor.authorKhoo, CC
dc.contributor.authorKontovounisios, C
dc.contributor.authorPellino, G
dc.contributor.authorChong, I
dc.contributor.authorTait, D
dc.contributor.authorWarren, OJ
dc.contributor.authorBower, M
dc.contributor.authorTekkis, P
dc.contributor.authorMills, SC
dc.date.accessioned2021-04-08T10:30:19Z
dc.date.available2021-04-08T10:30:19Z
dc.date.issued2021-02-11
dc.identifierhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000620502800002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=d4b848928d1c3e5c86d298abb68475f9
dc.identifierARTN 3
dc.identifier.citationDISCOVER ONCOLOGY, 2021, 12 (1), pp. ? - ? (10)
dc.identifier.issn1868-8497
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/4498
dc.identifier.eissn2730-6011
dc.identifier.doi10.1007/s12672-021-00397-7
dc.description.abstractAnal Squamous Cell Carcinoma (ASCC) is a rare cancer that has a rapidly increasing incidence in areas with highly developed economies. ASCC is strongly associated with HIV and there appears to be increasing numbers of younger male persons living with HIV (PLWH) diagnosed with ASCC. This is a retrospective cohort study of HIV positive and HIV negative patients diagnosed with primary ASCC between January 2000 and January 2020 in a demographic group with high prevalence rates of HIV. One Hundred and seventy six patients were included, and clinical data was retrieved from multiple, prospective databases. A clinical subgroup was identified in this cohort of younger HIV positive males who were more likely to have had a prior diagnosis of Anal Intraepithelial Neoplasia (AIN). Gender and HIV status had no effect on staging or disease-free survival. PLWH were more likely to develop a recurrence (p < 0.000) but had a longer time to recurrence than HIV negative patients, however this was not statistically significant (46.1 months vs. 17.5 months; p = 0.077). Patients known to have a previous diagnosis of AIN were more likely to have earlier staging and local tumour excision. Five-year Disease-Free Survival was associated with tumour size and the absence of nodal or metastatic disease (p < 0.000).
dc.format.extent? - ? (10)
dc.languageeng
dc.language.isoeng
dc.publisherSPRINGER
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectScience & Technology
dc.subjectLife Sciences & Biomedicine
dc.subjectOncology
dc.subjectEndocrinology & Metabolism
dc.subjectAnal squamous cell carcinoma
dc.subjectHIV
dc.subjectChemoradiotherapy
dc.subjectGUIDELINES
dc.subjectCANCERS
dc.subjectMANAGEMENT
dc.subjectCOLON
dc.subjectMEN
dc.subjectHPV
dc.titleAnal squamous cell carcinoma in a high HIV prevalence population.
dc.typeJournal Article
dcterms.dateAccepted2021-01-26
rioxxterms.versionVoR
rioxxterms.versionofrecord10.1007/s12672-021-00397-7
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2021-02-11
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfDISCOVER ONCOLOGY
pubs.issue1
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Ashworth Collaborators
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Ashworth Collaborators
pubs.publication-statusPublished
pubs.volume12
pubs.embargo.termsNot known
icr.researchteamAshworth Collaborators
icr.researchteamAshworth Collaborators
dc.contributor.icrauthorChong, Yu-Shing


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0